Active hexose correlated compound (AHCC) improves immunological parameters and performance status of patients with solid tumors

Biotherapy

Volumn 14, Issue 3, 2000, Pages 303-309

  Uno, K ^a   Kosuna, K ^a   Sun, B ^a   Fujii, H ^a   Wakame, K ^a   Chikumaru, S ^a   Hosokawa, G ^a   Ueda, Y ^a  

^a Comfort Medical Foundation ^*  (Japan)

Author keywords

AHCC; Cancer; Interferon gamma; Interleukin 12; Natural killer cell activity

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; GAMMA INTERFERON; HEXOSE; INTERLEUKIN 12;

ADULT; AGED; ARTICLE; CANCER IMMUNOLOGY; CELL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG ACTIVITY; DRUG EFFECT; FEMALE; HUMAN; MALE; MONONUCLEAR CELL; NATURAL KILLER CELL; SOLID TUMOR; TUMOR GROWTH;

EID: 0034099086     PISSN: 09142223     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)